📊 Score Breakdown
Offering Ability
40
Cash Runway
65
Float Risk
30
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
45%
🔁 Convertible Conversion
60%
• Major convertible overhang: 182% potential dilution
• Convertible risk score very high (85/100)
📉 Score Deterioration
40%
• Score rose 37 points recently (worsening)
💰 Capital Raise
15%
• Under 12 months cash (11mo)
💹 Market Data
Market Cap$8.20M
Shares Outstanding5.50M
Float5.26M
Cash$32.65M
Debt$22.85M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 34.9% shares (2025Q4 vs prior)
77 institutional holders · 25.90M shares
#1
VANGUARD GROUP INC
5.65M shares
#2
Cresset Asset Management, LLC
2.92M shares
#3
BlackRock, Inc.
1.96M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest452.7K
Days to Cover1.0
% of Float8.6%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Dec 31, 2025
xbrl
XBRL WARRANT
Dec 31, 2023
4
INSIDER TRANSACTION
Mar 05, 2026
4
INSIDER TRANSACTION
Mar 05, 2026
4
INSIDER TRANSACTION
Mar 05, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for ORGN
📊 ORGN FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 ORGN Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.